4
Changes in Ownership
SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-24-006396
Chief Commercial Officer acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Francomano Robert Chief Commercial Officer | 2024-01-22 | Grant or award | +20,000 | 40,918 | D | ||
| Derivatives | |||||||
| Francomano Robert Chief Commercial Officer | 2024-01-22 | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | D | ||
Loading xslF345X05/tm243935-2_4seq1.xml…